Chugai reports on Roche’s Q3 2025 sales

Chugai Pharmaceutical Co., Ltd. today released an announcement regarding the third-quarter (January 1 – September 30, 2025) sales performance of its parent company, F. Hoffmann-La Roche Ltd. (Head Office: Basel, Switzerland; chief executive: Thomas Schinecker).

Roche Holding Ltd, the parent company for both Roche and Chugai, held 59.89% of Chugai's issued shares and 61.11% of voting rights as of the end of June 2025. The results of the Roche Group's performance for this period, which include Chugai's performance, are available on the Roche website.